Please login to the form below

Not currently logged in
Email:
Password:

Vazkepa

This page shows the latest Vazkepa news and features for those working in and with pharma, biotech and healthcare.

CHMP recommends EU approval for Amarin’s cardiovascular risk reduction drug

CHMP recommends EU approval for Amarin’s cardiovascular risk reduction drug

The CHMP has adopted a positive opinion for marketing authorisation of the drug under the brand name Vazkepa in the EU.

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Havas Lynx Group

We are the Havas Lynx Group. Devoted to fresh thinking. Changing the way the world does healthcare communications for the...

Latest intelligence

Want to give perfect client service? Tough luck, you’re human
In this article an ex-client of mine, Liz Skrbkova, and I explore the (unhelpful) pressures of trying to perfect the client-agency relationship...
WHITE PAPER: Why do men die younger?
It’s a commonly accepted fact that women outlive men. Wherever you live, there’s a good chance that men will die on average eight years earlier than women. Is this an...
3 tips to show patient diversity in your clinical trial materials
Here are some useful tips to help get your hands on authentically diverse stock photos....

Infographics